Status:
RECRUITING
The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia
Lead Sponsor:
Muş Alparslan University
Conditions:
SCHIZOPHRENIA 1 (Disorder)
Psychosocial Adaptation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophr...
Detailed Description
Objective: Schizophrenia is a chronic psychiatric disorder that significantly affects thought, emotion, and behavior, often limiting social functioning, treatment adherence, and integration into dail...
Eligibility Criteria
Inclusion
- Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria,
- Being between 18 and 65 years of age,
- Being literate and verbally communicative,
- Being clinically stable (not exhibiting symptoms of acute psychosis),
- Being registered with a Community Mental Health Center (CMHC) and receiving regular services,
- Being cognitively competent enough to participate in individual interviews during the research process,
- Being an individual currently receiving psychiatric treatment and taking medication,
- Agreeing to participate voluntarily in the study and signing a written informed consent form.
Exclusion
- those who do not meet the inclusion criteria
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 25 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07144592
Start Date
January 1 2025
End Date
October 25 2025
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Mental Health Center
Muş, Turkey (Türkiye)